Search research articles
Contact Us
Filters
Showing results (1-10 of 57) with videos related to
Page
of 6
Sort By:
Assay and Drug Development Technologies
|
September 11, 2004
An interview with Steven M. Watkins, Ph.D., president and chief scientific officer, Lipomics Technologies, Inc. Interview by Vicki Glaser
Steven M Watkins
Current Opinion in Drug Discovery & Development
|
February 26, 2004
Lipomic profiling in drug discovery, development and clinical trial evaluation
Steven M Watkins
Current Opinion in Chemical Biology
|
June 28, 2005
Focused metabolomic profiling in the drug development process: advances from lipid profiling
Macdonald Morris, Steven M Watkins
Current Opinion in Biotechnology
|
December 3, 2002
Toward the implementation of metabolomic assessments of human health and nutrition
Steven M Watkins, J Bruce German
Circulation Research
|
August 4, 2012
Promoting atherosclerosis in type 1 diabetes through the selective activation of arachidonic acid and PGE(2) production
Steven M Watkins, Gökhan S Hotamisligil
Current Opinion in Lipidology
|
March 14, 2007
Biomarker discovery using high-dimensional lipid analysis
Michelle M Wiest, Steven M Watkins
Current Opinion in Molecular Therapeutics
|
July 26, 2002
Metabolomics and biochemical profiling in drug discovery and development
Steven M Watkins, J Bruce German
Cell Metabolism
|
May 8, 2012
The role of endoplasmic reticulum in hepatic lipid homeostasis and stress signaling
Suneng Fu, Steven M Watkins, Gökhan S Hotamisligil
The Journal of Nutrition
|
November 11, 2003
Phosphatidylethanolamine-N-methyltransferase activity and dietary choline regulate liver-plasma lipid flux and essential fatty acid metabolism in mice
Steven M Watkins, Xiaonan Zhu, Steven H Zeisel
Metabolomics : Official Journal of the Metabolomic Society
|
May 9, 2006
Metabolomics: building on a century of biochemistry to guide human health
J Bruce German, Bruce D Hammock, Steven M Watkins
Page
of 6
Search research articles
Search
Showing results (1-10 of 57) with videos related to
Sort By:
Page
of 6
Assay and Drug Development Technologies
|
September 11, 2004
An interview with Steven M. Watkins, Ph.D., president and chief scientific officer, Lipomics Technologies, Inc. Interview by Vicki Glaser
Steven M Watkins
Current Opinion in Drug Discovery & Development
|
February 26, 2004
Lipomic profiling in drug discovery, development and clinical trial evaluation
Steven M Watkins
Current Opinion in Chemical Biology
|
June 28, 2005
Focused metabolomic profiling in the drug development process: advances from lipid profiling
Macdonald Morris, Steven M Watkins
Current Opinion in Biotechnology
|
December 3, 2002
Toward the implementation of metabolomic assessments of human health and nutrition
Steven M Watkins, J Bruce German
Circulation Research
|
August 4, 2012
Promoting atherosclerosis in type 1 diabetes through the selective activation of arachidonic acid and PGE(2) production
Steven M Watkins, Gökhan S Hotamisligil
Current Opinion in Lipidology
|
March 14, 2007
Biomarker discovery using high-dimensional lipid analysis
Michelle M Wiest, Steven M Watkins
Current Opinion in Molecular Therapeutics
|
July 26, 2002
Metabolomics and biochemical profiling in drug discovery and development
Steven M Watkins, J Bruce German
Cell Metabolism
|
May 8, 2012
The role of endoplasmic reticulum in hepatic lipid homeostasis and stress signaling
Suneng Fu, Steven M Watkins, Gökhan S Hotamisligil
The Journal of Nutrition
|
November 11, 2003
Phosphatidylethanolamine-N-methyltransferase activity and dietary choline regulate liver-plasma lipid flux and essential fatty acid metabolism in mice
Steven M Watkins, Xiaonan Zhu, Steven H Zeisel
Metabolomics : Official Journal of the Metabolomic Society
|
May 9, 2006
Metabolomics: building on a century of biochemistry to guide human health
J Bruce German, Bruce D Hammock, Steven M Watkins
Page
of 6